Compass Pathways completed its NDA for COMP360 based on 2 phase 3 trials and a phase 2b study with more than 1000 participants with highly chronic TRD.
|Articles|November 12, 2010
Thorazine: The Drug That Redefined Psychiatry
See how the introduction of thorazine to the market changed the face of psychiatry practice.
Advertisement
When Thorazine was introduced in 1955, it was hailed for producing a "chemical lobotomy."
Advertisement
Related to this article
Advertisement
Advertisement
Trending on HCPLive
1
Don't Miss a Beat: What Lp(a)HORIZON and ZEUS Teach About Clinical Trial Science
2
What’s New in the 2027 GOLD Report for COPD
3
Rezpegaldesleukin's Early Treg Signal in AD: Emma Guttman-Yassky, MD
4
Enlicitide Lowers LDL-C Consistently Across PREVENT CVD Risk Categories
5